Blood Dialyzer

Blood Dialyzer Market Outlook

The global blood dialyzer market is anticipated to reach USD 12 billion by 2033, growing at a CAGR of 7.5% during the forecast period from 2025 to 2033. This growth is attributed primarily to the increasing prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD), necessitating effective dialysis solutions. Furthermore, advancements in technology and innovations in dialysis equipment, such as wearable and implantable dialyzers, are expected to significantly contribute to market growth. The rising geriatric population coupled with lifestyle diseases, and increased healthcare expenditures, especially in emerging economies, are also pivotal factors driving demand. As healthcare systems worldwide evolve and prioritize renal care, the blood dialyzer market is projected to witness substantial expansion in the forthcoming years.

Growth Factor of the Market

Several growth factors are propelling the blood dialyzer market forward. The rising incidence of chronic diseases, particularly diabetes and hypertension, has significantly increased the prevalence of CKD, thereby creating a higher demand for effective dialysis solutions. Additionally, the expansion of healthcare infrastructure and increased accessibility to dialysis services in developing regions have further boosted market growth. Innovations in dialyzer technology, such as improved biocompatibility and the use of advanced materials, enhance treatment efficacy and patient comfort, driving adoption rates higher. The trend toward home dialysis solutions is also gaining momentum, as patients seek more flexible options, prompting manufacturers to develop user-friendly home dialysis products. Lastly, ongoing research and development aimed at improving the efficiency of dialyzers continues to create new opportunities in the market.

Key Highlights of the Market

• The blood dialyzer market is projected to grow at a CAGR of 7.5% through 2033.
• Technological advancements are leading to the development of innovative dialyzer products.
• Home care settings are emerging as a significant segment for dialyzer applications.
• North America holds a substantial market share, driven by advanced healthcare infrastructure.
• Collaborations and partnerships among key players are increasingly shaping the competitive landscape.

By Product Type

Hemodialyzers:

Hemodialyzers, commonly known as artificial kidneys, play a pivotal role in the blood dialyzer market. These devices utilize a semi-permeable membrane to remove toxins and excess fluids from the blood of patients suffering from kidney failure. The increasing prevalence of renal diseases and the growing number of hemodialysis patients are significant factors driving the demand for these products. Hemodialyzers are typically used in clinical settings and hospitals, where patients undergo regular dialysis treatments. Innovations in hemodialyzer technology, including improved biocompatibility and increased surface area for better filtration, are enhancing their efficacy and patient comfort, thus promoting market growth.

Peritoneal Dialyzers:

Peritoneal dialyzers utilize the body’s own peritoneal membrane to remove waste products and excess fluid from the blood, representing an alternative to traditional hemodialysis. The rise in patient preference for home-based care and the convenience offered by peritoneal dialysis treatments are driving the demand for peritoneal dialyzers. Moreover, these devices are particularly effective for patients who may have difficulty accessing hemodialysis due to vascular access issues. The expansion of educational programs by healthcare providers to promote peritoneal dialysis is also influencing market growth, as more patients are made aware of the benefits of this treatment option.

Continuous Renal Replacement Therapy (CRRT) Systems:

CRRT systems are designed for critically ill patients who require continuous, slow dialysis treatment. This type of therapy is particularly suitable for patients in intensive care settings who may not tolerate traditional hemodialysis. The growing awareness of the risks associated with acute kidney injury (AKI) and the increasing incidence of multi-organ failure in critically ill patients are contributing to the demand for CRRT systems. Additionally, advancements in CRRT technology, such as improved filtration membranes and automated systems for easier operation, are making these devices more attractive to healthcare providers, further driving market growth.

Wearable Dialyzers:

Wearable dialyzers represent a cutting-edge innovation in the blood dialyzer market, providing patients with more flexibility and independence. These devices can be worn on the body and enable patients to engage in daily activities while undergoing dialysis treatment. The development of wearable technology in healthcare is prompting significant interest in these devices, particularly among younger patients seeking convenience. Moreover, the ongoing research in miniaturization and efficiency of wearable dialyzers is likely to usher in a new era of dialysis, potentially increasing patient compliance and improving quality of life.

Implantable Dialyzers:

Implantable dialyzers are an emerging product type, designed for long-term dialysis treatment without the need for regular clinic visits. This innovation aims to improve patient outcomes and reduce hospital visits, particularly for those with chronic kidney disease. As technology advances, the feasibility and safety of implantable devices are becoming more viable, leading to increased acceptance among patients and healthcare providers. The potential for reduced complications associated with traditional dialysis methods further fuels interest in this segment, indicating a promising future for implantable dialyzers in the market.

By Continuous Renal Replacement Therapy

Intermittent Renal Replacement Therapy (IRRT):

Intermittent renal replacement therapy (IRRT) is characterized by periodic short sessions of dialysis, making it suitable for patients who may not tolerate continuous therapy. This approach is often utilized for patients in stable conditions or those transitioning from acute to chronic care. The flexibility offered by IRRT allows for individualized treatment plans, catering to the specific needs of patients. Increased awareness and the growing incidence of acute kidney injury (AKI) are driving the demand for IRRT solutions, as healthcare providers seek effective management strategies for critically ill patients.

Continuous Venovenous Hemodialysis (CVVHD):

Continuous venovenous hemodialysis (CVVHD) offers a method of renal replacement therapy that continuously removes excess fluid and waste from the blood. This approach is particularly beneficial for patients in intensive care units, where hemodynamic stability is essential. The ability to fine-tune fluid removal rates to avoid hemodynamic instability is contributing to the increasing adoption of CVVHD protocols in critical care settings. Moreover, advancements in monitoring technologies are enhancing the safety and efficacy of CVVHD, further propelling its growth as a preferred option for continuous renal replacement therapy.

Continuous Venovenous Hemofiltration (CVVH):

Continuous venovenous hemofiltration (CVVH) is another modality within continuous renal replacement therapy that focuses on the removal of larger waste particles from the blood. It involves the use of replacement fluids to maintain electrolyte balance, making it a suitable choice for patients with specific metabolic imbalances. The growing recognition of CVVH as a viable treatment option for patients with AKI and its application in various clinical settings are driving market expansion. Additionally, the increasing availability of advanced hemofiltration systems is likely to boost the adoption of CVVH in therapeutic protocols.

By Application

Hospitals:

Hospitals are a primary application sector for blood dialyzers, as they provide comprehensive care for patients with chronic kidney disease and acute kidney injury. The high patient volume in hospitals necessitates the use of advanced dialysis equipment to ensure effective treatment outcomes. Moreover, the availability of specialized nephrology departments and well-trained healthcare professionals in hospitals facilitates the delivery of high-quality dialysis services. As the incidence of kidney-related ailments continues to rise, hospitals are increasingly investing in state-of-the-art dialysis technologies, thereby significantly contributing to the growth of the blood dialyzer market.

Clinics:

Clinics serve as an essential application segment for blood dialyzers, providing accessible treatment options for patients with chronic kidney conditions. Outpatient clinics often offer hemodialysis services, catering to patients who prefer receiving treatment in a less intensive setting compared to hospitals. The convenience of clinics allows for regular monitoring and management of renal health, fostering better patient adherence to dialysis schedules. As the focus on outpatient care increases, the demand for dialyzers in clinics is expected to grow, supported by advancements in technology that enhance the efficacy and safety of outpatient dialysis treatments.

Home Care Settings:

Home care settings are emerging as a significant application area for blood dialyzers, driven by the growing preference for home-based dialysis solutions. Patients increasingly seek flexibility and comfort, making home dialysis an attractive option, especially for those with chronic kidney disease. This trend has resulted in manufacturers focusing on developing user-friendly devices and providing adequate training and support for patients and caregivers. The convenience of home care not only improves patient quality of life but also potentially reduces healthcare costs, making it a preferred choice for many patients and their families.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly integrating dialysis treatments into their service offerings, catering to patients requiring short-term dialysis procedures. The growing trend of outpatient surgeries and the need for efficient pre- and post-operative care have led to the adoption of dialyzers in ASCs. These centers provide a cost-effective alternative to traditional hospital settings, enabling patients to receive timely dialysis without extended hospital stays. As the demand for outpatient surgical procedures rises, the incorporation of dialysis solutions in ASCs is projected to grow, contributing to the overall expansion of the blood dialyzer market.

By Distribution Channel

Direct Sales:

Direct sales channels play a crucial role in the distribution of blood dialyzers, allowing manufacturers to establish direct relationships with healthcare providers. This approach facilitates better communication and understanding of customer needs, enabling manufacturers to tailor their products and services accordingly. Direct sales also empower manufacturers to provide training and support directly to healthcare professionals, ensuring optimal utilization of dialyzer products. As the healthcare landscape evolves, the direct sales model is becoming increasingly prominent, with many companies emphasizing customer engagement and service excellence.

Distributor Sales:

Distributor sales represent a significant distribution channel for blood dialyzers, leveraging established networks to reach a broader customer base. Distributors have the logistical capabilities to efficiently manage inventory and supply chain operations, allowing manufacturers to focus on product development and innovation. This channel is particularly beneficial for reaching smaller clinics and outpatient facilities that may not have direct purchasing power. As the demand for renal care continues to grow, the role of distributors in ensuring timely delivery and availability of blood dialyzers will remain critical to market success.

By Material Type

Synthetic:

Synthetic materials are widely used in the production of blood dialyzers, offering advantages such as enhanced biocompatibility and reduced risk of allergic reactions. Synthetic dialyzers are engineered to improve the efficiency of waste removal, making them suitable for a diverse patient population. The growing preference for synthetic materials stems from their durability and consistency in performance, leading to better patient outcomes. As manufacturers continue to innovate and develop new synthetic materials with improved properties, the demand for synthetic dialyzers is expected to rise significantly in the coming years.

Cellulose-Based:

Cellulose-based dialyzers have been a traditional choice in dialysis treatments, known for their affordability and effectiveness. These dialyzers utilize natural cellulose membranes, offering reliable filtration capabilities for patients. While cellulose-based products have been foundational in the industry, they may be less biocompatible compared to synthetic alternatives. However, the ongoing development of modified cellulose membranes aims to enhance their performance and biocompatibility, thereby sustaining their relevance in the market. The affordability of cellulose-based dialyzers continues to attract healthcare facilities, particularly in regions with budget constraints.

Polysulfone:

Polysulfone dialyzers are recognized for their high permeability and superior filtration efficiency, making them a popular choice among healthcare providers. The unique properties of polysulfone membranes allow for effective removal of larger molecules, enhancing patient outcomes during dialysis treatment. The increasing prevalence of chronic kidney diseases and the demand for high-performance dialyzers are driving the growth of the polysulfone segment. Manufacturers are continually working to optimize polysulfone technology, focusing on improving membrane characteristics and enhancing overall treatment efficacy.

Polyethersulfone:

Polyethersulfone (PES) dialyzers are gaining traction in the market due to their excellent hydrophilicity and mechanical strength. PES membranes offer high stability and are less prone to fouling, ensuring consistent performance during dialysis sessions. The advantages of PES dialyzers over traditional materials have led to increased adoption, particularly in advanced healthcare markets. As research progresses, manufacturers are investing in PES technology to enhance its properties further, aiming to provide better solutions for patients with varying renal conditions. The growing awareness of the benefits of PES products is expected to drive market growth in this segment.

Polyethylene:

Polyethylene is increasingly being utilized in the production of blood dialyzers, particularly for its biocompatibility and versatility. Polyethylene-based membranes have shown promising results in terms of filtration efficiency and safety for patients. The adaptability of polyethylene in manufacturing processes allows for the creation of customized devices to meet specific patient needs. As the focus on patient-centered care intensifies, the demand for polyethylene materials in blood dialyzers is projected to rise. Moreover, ongoing research into enhancing the properties of polyethylene membranes is likely to contribute to the growth of this segment in the blood dialyzer market.

By Region

The North America blood dialyzer market holds a prominent position globally, driven by advanced healthcare infrastructure, high prevalence of chronic kidney diseases, and extensive research and development activities. In 2023, the North American market was valued at approximately USD 4 billion, with a projected CAGR of 6.8% through 2033. The United States is a significant contributor to this market, owing to the concentration of leading medical technology companies and a robust reimbursement framework for dialysis treatments. Furthermore, increased awareness regarding renal health and the availability of advanced dialysis technologies are expected to sustain market growth in this region.

In Europe, the blood dialyzer market is also experiencing notable growth, with a market value of around USD 3 billion in 2023. The European market is characterized by a high demand for home dialysis options as patients aim for improved quality of life. The increasing aging population and rising incidence of diabetes and hypertension further support this trend. Additionally, favorable regulatory policies and initiatives promoting renal care are expected to drive market expansion across European countries. The Asia Pacific region is emerging rapidly in the blood dialyzer market, with significant growth expected due to increasing healthcare investments and the rising prevalence of renal diseases. However, the total market value in the Asia Pacific is expected to sum up to around USD 2.5 billion, reflecting a CAGR of 8.2% during the forecast period.

Opportunities

The blood dialyzer market presents numerous opportunities for growth, particularly in emerging economies where the prevalence of chronic kidney diseases is on the rise. As healthcare systems in these regions continue to develop, there is an increasing demand for affordable and accessible dialysis solutions. Manufacturers can capitalize on this opportunity by tailoring their products to meet the unique needs of patients in these markets, including the development of low-cost dialyzers and training programs for healthcare providers. Additionally, collaborations with local healthcare organizations can facilitate market entry and enhance service delivery, further driving the growth of the blood dialyzer segment in these regions.

Moreover, advancements in technology are paving the way for innovative product development within the blood dialyzer market. The emergence of wearable and implantable dialyzers is creating new avenues for manufacturers to explore, appealing to a growing patient demographic seeking more convenient treatment options. Research and development focused on enhancing the biocompatibility and efficiency of dialyzers will likely result in improved patient outcomes, thus fostering greater adoption of these advanced solutions. As healthcare providers continue to prioritize patient-centered care, the demand for innovative dialysis products is expected to surge, presenting ample opportunities for companies operating within this market.

Threats

Despite the promising growth projections for the blood dialyzer market, several threats could hinder its expansion. One notable challenge is the increasing competition among manufacturers, which may lead to price wars and reduced profit margins. Companies must continuously innovate and differentiate their products to maintain competitiveness in a crowded marketplace. Furthermore, stringent regulatory requirements for medical devices can pose challenges for manufacturers, particularly smaller companies with limited resources for compliance. Adhering to these regulations is crucial to ensure product safety and efficacy, but the associated costs and timeframes can become barriers to market entry and expansion.

Another significant threat in the blood dialyzer market is the potential for economic downturns that could affect healthcare spending. In times of economic uncertainty, governments and healthcare providers may implement budget cuts that could impact the availability of dialysis services and the procurement of advanced dialysis equipment. Additionally, the growing trend of patient self-management and home dialysis could lead to a decline in demand for traditional dialysis services, posing a challenge for healthcare facilities reliant on steady patient volumes. Companies must stay agile and adapt to these evolving market dynamics to navigate potential threats effectively.

Competitor Outlook

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Davita Inc.
• Asahi Kasei Corporation
• Medtronic plc
• Teleflex Incorporated
• Nipro Corporation
• Kawasumi Laboratories Inc.
• Toray Industries Inc.
• Gambro (now part of Baxter)
• B. Braun Melsungen AG
• Roche Diagnostics
• Hollister Incorporated
• Quanta Dialysis Technologies Ltd.
• RenalSense Ltd.

The competitive landscape of the blood dialyzer market is characterized by a mix of established players and emerging companies, each contributing to the market's growth through innovation and strategic partnerships. Major companies such as Baxter International Inc. and Fresenius Medical Care AG & Co. KGaA hold significant market shares due to their extensive product portfolios and strong distribution networks. These companies are consistently investing in research and development to enhance product performance and expand their offerings in the dialysis market. Furthermore, collaborations with healthcare providers and ongoing clinical trials are pivotal in ensuring that these companies remain at the forefront of market advancements.

Davita Inc. is another key player in the blood dialyzer market, specializing in dialysis services and products. The company has established a strong reputation for providing high-quality patient care and innovative dialysis solutions. Through strategic acquisitions and partnerships, Davita continues to strengthen its market position while expanding its service capabilities. Moreover, as the demand for home dialysis solutions grows, companies are adjusting their strategies to include a broader range of products and services that cater specifically to this segment.

Emerging companies such as Quanta Dialysis Technologies Ltd. and RenalSense Ltd. are making strides in the blood dialyzer market by focusing on innovative technologies such as wearable and implantable dialyzers. These companies are capitalizing on the growing trend of at-home care and patient-centered solutions, offering devices that enhance the patient experience while improving health outcomes. As these companies continue to gain traction, they may disrupt the traditional marketplace, prompting established players to adapt and innovate further to maintain their competitive edge.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Davita Inc.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 RenalSense Ltd.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Nipro Corporation
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 B. Braun Melsungen AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Teleflex Incorporated
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Toray Industries Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hollister Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Asahi Kasei Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Baxter International Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Kawasumi Laboratories Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Gambro (now part of Baxter)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Quanta Dialysis Technologies Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fresenius Medical Care AG & Co. KGaA
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Blood Dialyzer Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Home Care Settings
    • 6.1.4 Ambulatory Surgical Centers
  • 6.2 Blood Dialyzer Market, By Product Type
    • 6.2.1 Hemodialyzers
    • 6.2.2 Peritoneal Dialyzers
    • 6.2.3 Continuous Renal Replacement Therapy (CRRT) Systems
    • 6.2.4 Wearable Dialyzers
    • 6.2.5 Implantable Dialyzers
  • 6.3 Blood Dialyzer Market, By Material Type
    • 6.3.1 Synthetic
    • 6.3.2 Cellulose-Based
    • 6.3.3 Polysulfone
    • 6.3.4 Polyethersulfone
    • 6.3.5 Polyethylene
  • 6.4 Blood Dialyzer Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Blood Dialyzer Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Blood Dialyzer market is categorized based on

By Product Type

• Hemodialyzers
• Peritoneal Dialyzers
• Continuous Renal Replacement Therapy (CRRT) Systems
• Wearable Dialyzers
• Implantable Dialyzers

By Application

• Hospitals
• Clinics
• Home Care Settings
• Ambulatory Surgical Centers

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material Type

• Synthetic
• Cellulose-Based
• Polysulfone
• Polyethersulfone
• Polyethylene

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Baxter International Inc.
• Fresenius Medical Care AG & Co. KGaA
• Davita Inc.
• Asahi Kasei Corporation
• Medtronic plc
• Teleflex Incorporated
• Nipro Corporation
• Kawasumi Laboratories Inc.
• Toray Industries Inc.
• Gambro (now part of Baxter)
• B. Braun Melsungen AG
• Roche Diagnostics
• Hollister Incorporated
• Quanta Dialysis Technologies Ltd.
• RenalSense Ltd.